Table 1.
Demographic and clinical characteristics of TCGA-LIHC cohort
| Characteristics | Number of pts (%) |
|---|---|
| Age (years) | |
| <55 | 118 (31.89) |
| ≥55 | 252 (68.11) |
| Gender | |
| Female | 119 (32.08) |
| Male | 252 (67.92) |
| Histological type | |
| Fibrolamellar carcinoma | 3 (0.81) |
| Hepatocellular carcinoma | 361 (97.3) |
| Hepatocholangiocarcinoma (mixed) | 7 (1.89) |
| Histologic grade | |
| G1 | 55 (14.82) |
| G2 | 174 (46.9) |
| G3 | 125 (33.69) |
| G4 | 13 (3.5) |
| NA | 4 (1.08) |
| Stage | |
| I | 172 (46.36) |
| II | 86 (23.18) |
| III | 85 (22.91) |
| IV | 5 (1.35) |
| NA | 23 (6.2) |
| T classification | |
| T1 | 181 (48.79) |
| T2 | 94 (25.34) |
| T3 | 80 (21.56) |
| T4 | 13 (3.5) |
| TX | 1 (0.27) |
| NA | 2 (0.54) |
| N classification | |
| N0 | 254 (68.46) |
| N1 | 4 (1.08) |
| NX | 112 (30.19) |
| NA | 1 (0.27) |
| M classification | |
| M0 | 268 (72.24) |
| M1 | 4 (1.08) |
| MX | 99 (26.68) |
| Residual tumor | |
| R0 | 326 (87.87) |
| R1 | 16 (4.31) |
| R2 | 1 (0.27) |
| RX | 21 (5.66) |
| NA | 7 (1.89) |
| Vital status | |
| Deceased | 128 (34.5) |
| Living | 243 (65.5) |
| Recurrence | |
| No | 178 (55.8) |
| Yes | 141 (44.2) |
Abbreviation: NA, not available.